Of us in a team effort to make sure that there are no gaps in the actual supply. as you mentioned, the fda, we ve talked about the fda says it s doing its best to help do what it can to increase production. the fact that one abbott plant was shut down in february, i think leaves a lot of people scratching their heads that maybe one plant could lead to this. does it really all go back to that one plant? as with other industries, there were some supply chain challenges last fall, but they were mostly resolved by the time that this product recall started in february, and so it really is mostly attributable to abbott nutrition s recall of several powdered infant formulas. and so i think that leaves a pretty strong question of how did we let the market get this centralized. in the wic space there s only three companies that compete for contracts in the wic space. you really start to question is there really competition here. does that mean, really quickly, does that mean you may